Testing effectiveness (Phase 2)Looking for participantsNCT03266653
What this trial is testing
EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection
Who this might be right for
Epstein-Barr Virus InfectionsPrimary Immune Deficiency Disorder
New York Medical College 20